MedTrace Logo

Primary Liver Cancer Cohort of South China

NCT03297255 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2017-09-29

No results posted yet for this study

Summary

This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. Basic informations and detailed diagnosis informations (AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage) were collected by professional doctors. Clinical outcomes (death, recurrence, and metastasis) will be followed up every two years after therapy.

Conditions

  • Primary Liver Cancer

Sponsors & Collaborators

  • Huilian Zhu

    lead OTHER

Principal Investigators

  • Zhu Huilian, Professor · Sun Yat-sen University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03297255 on ClinicalTrials.gov